Gene fusions, the result of chromosomal rearrangements such as translocations, inversions, deletions, or insertions, are integral in cancer biology. These rearrangements create chimeric genes, which have strategic importance in precision medicine. They serve as therapeutic biomarkers, aiding in the diagnosis, prognosis, and advancement of targeted therapies.
However, understanding the functional implications of these mutations remains a significant challenge. Traditional methodologies often utilize gene knockout or recombinant gene expression techniques, which may not adequately reflect the clinical complexity of chromosomal translocations. This limitation highlights the necessity of innovative experimental models.
CRISPR/Cas9 Platform
The CRISPR/Cas9 platform stands at the forefront of genetic editing, offering specialized services that enable researchers to effectively investigate the roles of fusion genes in tumor cells. Our approach allows for the precise customization of chromosomal architecture, including modifications for translocations, insertions, and deletions in selected cell lines.
Workflow
Our CRISPR/Cas9 gene fusion cell line services involve a comprehensive workflow designed to meet diverse research requirements:
- Expertise spanning over 200 distinct cell lines, ensuring familiarity with their culture and genetic backgrounds.
- Custom engineering to create specific gene fusions.
Service Offerings
Our services encompass:
- Development of chimeric genes at the chromosome level and cDNA knock-ins.
- Footprint-free genome editing to ensure non-disruptive integration.
- Creation of isogenic cell lines for reliable comparison.
- Extensive analyses of DNA, RNA, and protein levels using techniques such as RT-PCR, RNA-Seq, immunocytochemistry, fluorescence in situ hybridization, and Western blotting.
Why Choose Us?
Our advantages include:
- High efficiency and success rates exceeding 98%.
- A diverse range of available cell lines.
- Extensive experience with thousands of genetic editing projects.
- Customized deliverables, including both homozygous and hybrid clones.
- Short turnaround times and competitive pricing.
- Regular updates on project milestones and comprehensive final reports.
Applications
Our CRISPR/Cas9 gene fusion cell line services find applications in various fields, including:
- Modeling mutations relevant to clinical scenarios.
- Identification of molecular biomarkers for cancer prognosis.
- Drug discovery and screening processes.
- Research in immunotherapy.
At the CRISPR/Cas9 Platform, we have successfully generated thousands of cell lines across numerous models. We invite you to leverage our expertise for your upcoming research endeavors. Contact us to discuss your specific needs, and let us assist you with our comprehensive CRISPR/Cas9 gene editing solutions.
